Study Title: A Single Arm Phase I/II Study of Tazemetostat with Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma
- Open to Accrual at:
- Learn more:
Study Contact: studies@hoosiercancer.org; (317) 921-2050.
Subscribe to the Big Ten CRC Newsletter
Twitter
Facebook
YouTube